Expert Commentary

The crushing of innovation for treating female pelvic floor disorders: A story of “lead or be led”

OBG Manag. 2016 April;28(4)

References

Food and Drug Administration. Urogynecologic surgical mesh: update on the safety and effectiveness of transvaginal placement for pelvic organ prolapse. http://www.fda.gov/downloads/MedicalDevices/Safety/AlertsandNotices/UCM262760.pdf. Published July 2011. Accessed March 21, 2016.
Meyer CP, Trinh QD. Complications after surgery for stress urinary incontinence: untangling a mesh of uncertainties. JAMA Surg. 2015;150(12):1175-1176.
Food and Drug Administration Center for Devices and Radiological Health. Brief summary of the Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee Meeting--February 25, 2016. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/Gastroenterology-UrologyDevicesPanel/UCM488397.pdf. Accessed March 21, 2016.
Rosenbaum L. N-of-1--tragedy, trade-offs, and the demise of morcellation. N Engl J Med. 2016;374(10):986-990.
Kuran T, Sunstein C. Availability cascades and risk regulation. Stanford Law Rev. 1999;51:683-768.
Hippocratic oath, modern version. Adapted by Louis Lasagna. 1964. Johns Hopkins Sheridan Libraries and University Museums website. http://guides.library.jhu.edu/c.php?g=202502&p=1335759. Updated December 8, 2015. Accessed March 22, 2016.